COVID & Cancer
SCCAMP
Scottish COVID CAncer iMmunity Prevalence (SCCAMP) study Is COVID-19 immunity reduced in cancer patients? It is still uncertain to what extent cancer or cancer treatments
UK Coronavirus Cancer Monitoring – Edinburgh Group
Project overview The Edinburgh Cancer Centre (ECC), on behalf of SCAN (South East Scotland Cancer Network), are contributing to this national registry of cases of
Palliative Care
Reversal of the Polypharmacy-Survival Relationship in Poor Prognosis Cancer Patients
As seen at the CRUK Data Conference ’24 Estimation of prognosis is vital for informing decisions around care and its value, especially in patients with
I-Qual-PPC
The I-Qual-PPC project Improving the Quality and value of care for people with Poor Prognosis Cancers Context When discussing medical options, patients with poor prognosis
REVOLUTION
The purpose of the REVOLUTION study is to gather information about people with cancer. The aim is to gain a full picture of the physical,
Breast Cancer
Treatment sequencing in metastatic breast cancer
Edinburgh Cancer Centre Oncology Specialty Registrar Ashley Horne @AshHorne1983 used data visualisation to demonstrate the power of Scottish prescribing data for complex treatment sequencing in
SATURNE Project
The SATURNE Project A natural experiment using Scottish clinical data to estimate the real-world effectiveness of adjuvant chemotherapy in breast cancer patients Over 4,600 women
Real World Data for CDK 4/6 Inhibitor Evaluation in ER+ HER2- High Risk Early Breast Cancer
Despite adjuvant endocrine treatment (AET) advances, hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2−), node-positive early breast cancer (EBC) is associated with
HER2-RADICAL Trial
Edinburgh Cancer Informatics and Edinburgh Health Economics research groups are running the Data Science, Pathway Analysis and Health Economic Modelling as part of the UK
Pathological response as prognostic indicator for recurrence and survival in early triple negative breast cancer (eTNBC) – use case for multi-centre RWD to support patient access
Innovative new medicines used in conjunction with neoadjuvant chemotherapy (NACT) may lead to a higher pathological complete response (pCR), and therefore a better chance of
Patient Characteristics, Treatment Patterns and Long-term Outcomes from a Real-World Population of Early Breast Cancer Patients at High Risk of Recurrence in Scotland
In an effort to better describe patients affected with node-positive HR+, HER2− early breast cancer, the Edinburgh Cancer Informatics conducted a retrospective study looking at the
GI Cancer
Creation of the first national linked colorectal cancer dataset in Scotland
Prospects for future research and a reflection on lessons learned: The Bowel Cancer Intelligence UK Hub are working with Public Health Scotland and the University
PROMs/PREMs
KERMIT Study ePROMs Key Performance Indicators
What are ePROMs? Patient reported outcomes measures (PROMs) quanitify patient help and the effect of disease or treatment from the patient’s perspective. Their use in
Cancer PROMs pilot project with My Clinical Outcomes
SCAN, the South East Scotland Cancer Network, has been awarded funding from the Cancer Innovation Challenge to trial an implementation of a regional platform for
Brain Cancer
Brain Tumour Pathway – a REDCap Project
Brain Tumour Pathway – a REDCap Project Critical to accelerating the discovery of new therapies for brain tumours and their translation into the clinic,
Lung Cancer
Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre
Collaboration with the Edinburgh Cancer Informatics team enabled an investigation of the Real-World Impact of stereotactic ablative body radiotherapy (SABR) along with other conventional methods (conventional radiotherapy and surgery) on Stage
Prehab Project – A Lung Cancer Study Using REDCap
Summary by Dr Iain Phillips. The Edinburgh Cancer Informatics is supporting a prehabilitation project at St John’s hospital, Livingston, West Lothian for patients with likely
Early prehabilitation in suspected locally advanced and metastatic lung cancer
Lung cancer is the most common cause of cancer death in the UK. Our study aims to assess whether early prehabilitation is feasible in these